Global Pediatric Interventional Cardiology Market Size study, by Device Type, by Procedure, by End Use, and Regional Forecasts 2022-2032

Description

The Global Pediatric Interventional Cardiology Market is valued at approximately USD 2.6 billion in 2023 and is projected to grow at a healthy growth rate of more than 5.7% over the forecast period 2024-2032. Pediatric interventional cardiology, a specialized subset of cardiology, employs catheter-based techniques to treat heart disorders in infants, children, and adolescents up to 18 years of age. These techniques, such as balloon angioplasty, coil occlusion, stent implantation, and aortic valve stenosis, offer minimally invasive alternatives to conventional cardiological treatments, thereby reducing post-surgery complications. Consequently, they are extensively utilized in angioplasty, valvuloplasty, coronary thrombectomy, and congenital heart defect correction procedures across clinical testing laboratories, hospitals, cardiac centers, and research institutes.

The market is experiencing robust growth due to the increasing prevalence of congenital cardiac diseases in children, such as atrial septal defect (ASD), atrioventricular canal defect, patent ductus arteriosus (PDA), and ventricular septal defect (VSD). The introduction of novel pediatric interventional cardiology devices, including catheters, bio-absorbable stents, guidewires, balloons, stents, and vascular closure devices, is a significant growth driver. Additionally, the growing inclination toward non-invasive medical treatments, driven by benefits such as lower infection risk, shorter postoperative recovery times, and avoidance of large scars, is bolstering the market growth. Further, rising healthcare expenditure, government initiatives to expedite regulatory procedures, extensive research and development activities, and significant technological advancements in cardiology are creating a positive market outlook.

The key regions considered in the study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. North America dominated the market in 2023, owing to advanced healthcare infrastructure, high healthcare expenditure, and the presence of key market players. The Asia-Pacific region is expected to witness the fastest growth during the forecast period, driven by improving healthcare infrastructure, increasing healthcare spending, and rising awareness regarding pediatric interventional cardiology.

Major market players included in this report are:

Biotronik SE & Co. KG
Boston Scientific Corporation
Cardinal Health Inc.
Edwards Lifesciences Corporation
General Electric Company
Koninklijke Philips N.V.
Lepu Medical Technology (Beijing) Co. Ltd.
Medtronic plc
NuMED Inc.
Siemens Healthineers AG
Terumo CorporationW. L. Gore & Associates Inc.
B. Braun Melsungen AG
St. Jude Medical, Inc.
GE Healthcare
Cook Medical Inc.
Biosensors International Group Ltd
Nano Therapeutics Pvt. Ltd.

The detailed segments and sub-segment of the market are explained below:

By Device Type:

Closure Devices
Transcatheter Heart Valves
Atherectomy Devices
Catheters
Balloons
Stents
Others

By Procedure:

Catheter-Based Valve Implantation
Congenital Heart Defect Correction
Angioplasty
Coronary Thrombectomy
Others

By End Use:

Clinical Testing Laboratories
Hospitals
Cardiac Centers
Pediatric Clinics
Research Institutions

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Pediatric Interventional Cardiology Market Executive Summary

1.1. Global Pediatric Interventional Cardiology Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Device Type
- 1.3.2. By Procedure
- 1.3.3. By End Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Pediatric Interventional Cardiology Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Pediatric Interventional Cardiology Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing Instances of Congenital Cardiac Diseases
- 3.1.2. Shift Toward Non-Invasive Treatments
- 3.1.3. Technological Advancements in Cardiology
3.2. Market Challenges
- 3.2.1. High Costs of Pediatric Interventional Cardiology Devices
- 3.2.2. Regulatory Hurdles
3.3. Market Opportunities
- 3.3.1. Government Initiatives and Investments
- 3.3.2. Extensive R&D Activities
- 3.3.3. Rising Healthcare Expenditure

Chapter 4. Global Pediatric Interventional Cardiology Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Pediatric Interventional Cardiology Market Size & Forecasts by Device Type 2022-2032

5.1. Segment Dashboard
5.2. Global Pediatric Interventional Cardiology Market: Device Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Closure Devices
- 5.2.2. Transcatheter Heart Valves
- 5.2.3. Atherectomy Devices
- 5.2.4. Catheters
- 5.2.5. Balloons
- 5.2.6. Stents
- 5.2.7. Others

Chapter 6. Global Pediatric Interventional Cardiology Market Size & Forecasts by Procedure 2022-2032

6.1. Segment Dashboard
6.2. Global Pediatric Interventional Cardiology Market: Procedure Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Catheter-Based Valve Implantation
- 6.2.2. Congenital Heart Defect Correction
- 6.2.3. Angioplasty
- 6.2.4. Coronary Thrombectomy
- 6.2.5. Others

Chapter 7. Global Pediatric Interventional Cardiology Market Size & Forecasts by End Use 2022-2032

7.1. Segment Dashboard
7.2. Global Pediatric Interventional Cardiology Market: End Use Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Clinical Testing Laboratories
- 7.2.2. Hospitals
- 7.2.3. Cardiac Centers
- 7.2.4. Pediatric Clinics
- 7.2.5. Research Institutions

Chapter 8. Global Pediatric Interventional Cardiology Market Size & Forecasts by Region 2022-2032

8.1. North America Pediatric Interventional Cardiology Market
- 8.1.1. U.S. Pediatric Interventional Cardiology Market
  - 8.1.1.1. Device Type breakdown size & forecasts, 2022-2032
  - 8.1.1.2. Procedure breakdown size & forecasts, 2022-2032
  - 8.1.1.3. End Use breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Pediatric Interventional Cardiology Market
  - 8.1.2.1. Device Type breakdown size & forecasts, 2022-2032
  - 8.1.2.2. Procedure breakdown size & forecasts, 2022-2032
  - 8.1.2.3. End Use breakdown size & forecasts, 2022-2032
8.2. Europe Pediatric Interventional Cardiology Market
- 8.2.1. UK Pediatric Interventional Cardiology Market
  - 8.2.1.1. Device Type breakdown size & forecasts, 2022-2032
  - 8.2.1.2. Procedure breakdown size & forecasts, 2022-2032
  - 8.2.1.3. End Use breakdown size & forecasts, 2022-2032
- 8.2.2. Germany Pediatric Interventional Cardiology Market
- 8.2.3. France Pediatric Interventional Cardiology Market
- 8.2.4. Spain Pediatric Interventional Cardiology Market
- 8.2.5. Italy Pediatric Interventional Cardiology Market
- 8.2.6. Rest of Europe Pediatric Interventional Cardiology Market
8.3. Asia-Pacific Pediatric Interventional Cardiology Market
- 8.3.1. China Pediatric Interventional Cardiology Market
- 8.3.2. India Pediatric Interventional Cardiology Market
- 8.3.3. Japan Pediatric Interventional Cardiology Market
- 8.3.4. Australia Pediatric Interventional Cardiology Market
- 8.3.5. South Korea Pediatric Interventional Cardiology Market
- 8.3.6. Rest of Asia Pacific Pediatric Interventional Cardiology Market
8.4. Latin America Pediatric Interventional Cardiology Market
- 8.4.1. Brazil Pediatric Interventional Cardiology Market
- 8.4.2. Mexico Pediatric Interventional Cardiology Market
- 8.4.3. Rest of Latin America Pediatric Interventional Cardiology Market
8.5. Middle East & Africa Pediatric Interventional Cardiology Market
- 8.5.1. Saudi Arabia Pediatric Interventional Cardiology Market
- 8.5.2. South Africa Pediatric Interventional Cardiology Market
- 8.5.3. Rest of Middle East & Africa Pediatric Interventional Cardiology Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Biotronik SE & Co. KG
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Boston Scientific Corporation
- 9.3.3. Cardinal Health Inc.
- 9.3.4. Edwards Lifesciences Corporation
- 9.3.5. General Electric Company
- 9.3.6. Koninklijke Philips N.V.
- 9.3.7. Lepu Medical Technology (Beijing) Co. Ltd.
- 9.3.8. Medtronic plc
- 9.3.7. NuMED Inc.
- 9.3.8. Siemens Healthineers AG
- 9.3.9. Terumo Corporation
- 9.3.10. W. L. Gore & Associates Inc.
- 9.3.11. B. Braun Melsungen AG
- 9.3.12. St. Jude Medical, Inc.
- 9.3.12. GE Healthcare
- 9.3.13. Cook Medical Inc.
- 9.3.14. Biosensors International Group Ltd
- 9.3.15. Nano Therapeutics Pvt. Ltd.

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes